Phase Forward’s InForm GTM electronic data capture solution to be implemented by Bausch & Lomb

Phase Forward (NASDAQ: PFWD), a leading provider of data management solutions for clinical trials and drug safety, today announced a multi-year contract with renowned eye health company Bausch & Lomb. The agreement calls for Bausch & Lomb to implement Phase Forward’s InForm™ Global Trial Management (GTM) electronic data capture (EDC) solution, including the Central Coding™ module, in all of its trials, including Surgical, Vision Care and Pharmaceuticals products.

Bausch & Lomb will leverage Phase Forward’s InForm GTM to view and act on clinical trial data earlier in the development cycle, and enhance the efficiency and effectiveness with which it manages study procedures and expenditures. The Central Coding module – fully integrated with InForm – will be utilized to streamline the process of coding medical terms for trials, automating manual tasks while increasing coding consistency and accuracy.

“Bausch & Lomb is committed to the use of innovative technology to help develop the highest quality eye health products in the most efficient manner,” said John W. Sheets, Jr., corporate vice president and chief technology officer, Bausch & Lomb. “Clinical trials are a critical element of our product development engine, and Phase Forward’s EDC solution brings a proven solution for automating and optimizing trial management.”

“Bausch & Lomb enjoys a worldwide reputation for high quality eye health products,” said Bob Weiler, chairman and CEO, Phase Forward. “We are proud to be selected by a company of this caliber. Our mission is to become the trusted partner of all of our customers, and we bring this same commitment to this new relationship announced today.”